In the present study, we have assessed the use of non-viral S/MAR vectors carrying the human CHM coding sequence to produce functional human REP1 expression in CHM patient-derived cells and chm mutant zebrafish (chmru848), demonstrating the therapeutic potential of S/MAR vectors as non-viral alternatives for retinal gene therapy. This evidence concerns the gene CHM and choroideremia.